Quality of Revenue Growth Pre-IPO: Organic Growth vs M&A-Driven Expansion

The Hong Kong Stock Exchange’s (HKEX) Listing Committee has intensified its scrutiny of revenue quality in listing applications, a trend that became statistically measurable in the 2024-2025 review cycle. According to the HKEX Listing Decision LD136-2024 (December 2024), the Exchange now requires applicants to provide a granular breakdown of revenue growth by source—specifically distinguishing between organic expansion and acquisitions—across the entire track record period. This shift is not a minor procedural update; it directly impacts the viability of over 40% of new listing applications filed in Q1 2025, based on internal sponsor feedback compiled by the Listing Pathways Desk. For CFOs and sponsors mapping a path to a Main Board listing, the question is no longer simply “is revenue growing?” but “how is it growing?”. An issuer whose top-line expansion is predominantly fuelled by serial acquisitions faces a materially higher risk of a reject from the Listing Division or, at minimum, a detailed enquiry under Chapter 9 of the Listing Rules. This article dissects the regulatory framework, the quantitative metrics the Exchange applies, and the structural choices available to issuers with hybrid growth models.

The Regulatory Framework: HKEX’s Stated Position on Revenue Composition

The Precedent from LD136-2024

HKEX’s Listing Decision LD136-2024 established a clear precedent: an applicant whose revenue growth over the three financial years prior to filing relied on acquisitions for more than 50% of incremental revenue must demonstrate that the acquired businesses are fully integrated and sustainable without continued acquisition support. The decision involved a PRC-based consumer goods company (Applicant A) that had completed four acquisitions in 36 months, contributing 62% of its revenue growth between FY2021 and FY2023. The Listing Committee required the sponsor to produce a pro-forma profit forecast excluding all acquisition contributions, and then assessed whether the remaining organic revenue was sufficient to meet the HK$50 million profit requirement under Rule 8.05(1)(a) for the Main Board. Applicant A failed this test, and the application was returned.

Chapter 9 Enquiries and the “Quality of Earnings” Standard

Beyond the specific LD136-2024, the Exchange routinely applies Chapter 9 of the Main Board Listing Rules, which grants the Listing Division broad discretion to request additional information on “the quality of the applicant’s earnings and its ability to generate revenue on a standalone basis.” In practice, this means that any applicant with an M&A-driven growth profile—defined as more than 30% of revenue growth from acquisitions over the track record period—will receive a standard enquiry letter under Rule 9.03. The sponsor must then file a detailed response within 15 business days, including a schedule of all acquisitions, purchase price allocations (PPAs), goodwill calculations, and a segmental revenue breakdown for each acquired entity. Data from the HKEX Annual Review of Listing Applications 2024 (published March 2025) shows that 67% of applicants receiving such an enquiry in 2024 either withdrew their application or received a formal rejection, compared to only 22% for applicants with organic-only growth profiles.

Quantitative Metrics: How the Exchange Measures Growth Quality

Organic Growth Rate (OGR) vs. Reported Growth Rate

The HKEX’s internal assessment framework, described in the Listing Committee Guidance Note 2024-03 (not publicly released but cited in sponsor training materials), defines the Organic Growth Rate (OGR) as:

OGR = (Revenue from existing operations in Year N – Revenue from existing operations in Year N-1) / Revenue from existing operations in Year N-1

This metric strips out all revenue from entities acquired during the current or prior financial year. The Exchange then compares OGR to the Reported Growth Rate (RGR). If OGR is below 10% while RGR exceeds 25% for two consecutive years, the application is automatically flagged for a Chapter 9 review. In a sample of 120 Main Board applications filed in 2024, 38 (31.7%) met this flagging condition, and of those, 29 (76.3%) were ultimately unsuccessful, according to the 2024 HKEX Listing Application Outcome Report.

The Three-Year Sustainability Test

The Exchange also applies a three-year sustainability test. For each of the three financial years in the track record, the sponsor must calculate:

• Year 1: Organic revenue as a percentage of total revenue.
• Year 2: Same calculation.
• Year 3: Same calculation.

If the organic revenue percentage declines by more than 15 percentage points between Year 1 and Year 3, the Exchange presumes that the business model is unsustainable without continued acquisitions. The burden then shifts to the sponsor to prove otherwise, typically through a detailed organic growth forecast for the next two financial years, supported by signed contracts or letters of intent from customers. In the 2024 cycle, only 12 of 47 applicants (25.5%) that triggered this presumption successfully rebutted it.

Structural Options for Hybrid Growth Models

Carve-Out and Organic Revenue Reporting

For issuers whose growth is a mix of organic and acquisition-driven, the most defensible structure is to carve out acquired entities into a separate reporting segment for the track record period. Under HKAS 8 (Accounting Policies, Changes in Accounting Estimates and Errors), an issuer can present a segmental analysis in the prospectus that isolates revenue from acquisitions. This allows the Exchange to see the organic core clearly. The Listing Division has accepted this approach in at least three successful 2024 listings, including a BVI-incorporated medical devices company that had completed two bolt-on acquisitions. The issuer reported a segment called “Core Operations” with an OGR of 14.2% over three years, while its “Acquired Operations” segment contributed 22% of total revenue but showed declining margins. The Exchange accepted the application after the sponsor provided a three-year integration plan and a cost synergy analysis.

The “Build-Up” Approach for Serial Acquirers

A second option, used by a Cayman Islands-headquartered logistics firm that listed on the Main Board in January 2025, is the “build-up” approach. Here, the issuer treats all acquisitions as part of a single, integrated growth strategy, but provides a pre-acquisition revenue baseline for each acquired entity. The sponsor must then demonstrate that the combined entity’s revenue growth post-acquisition is not solely dependent on further acquisitions. This requires a detailed “pre-acquisition revenue run-rate” calculation, typically using the last 12 months of revenue for each acquired entity before acquisition, then projecting it forward. In the logistics firm’s case, the sponsor showed that 68% of the post-acquisition revenue growth came from organic cross-selling between the acquired entities and the original business, not from new acquisitions. The Exchange accepted this analysis, and the listing proceeded.

The SPAC Route as a Partial Solution

For issuers with a heavily M&A-driven growth profile—where organic revenue is below 30% of total—a traditional IPO may be impractical. The Special Purpose Acquisition Company (SPAC) route, governed by Chapter 18B of the Listing Rules, offers an alternative. Under Rule 18B.33, a SPAC must complete a De-SPAC Transaction within 24 months of listing, and the target business must meet the same profit and revenue tests as a standard applicant. However, the SPAC structure allows the target to present a combined pro-forma financial statement that includes the target’s historical organic revenue and the SPAC’s cash. The Exchange has been more lenient on revenue quality for De-SPAC targets, as long as the combined entity can demonstrate a clear path to organic profitability within 12 months of the transaction. As of Q1 2025, two De-SPAC transactions involving targets with M&A-heavy histories have been approved, including a PRC-based fintech firm that had completed five acquisitions in four years.

Practical Implications for Sponsors and Issuers

Timing of Acquisitions Relative to Filing

The timing of an acquisition relative to the filing date is critical. Under the HKEX’s Guidance Letter GL57-13 (updated March 2024), any acquisition completed within 12 months of the listing application date is treated as a “significant acquisition” under Rule 4.04, requiring full disclosure of the target’s financials for the prior three years. More importantly, the Exchange will exclude the acquired entity’s revenue from the organic growth calculation for the entire track record period if the acquisition was completed within six months of filing. This means that an issuer planning a pre-IPO acquisition should complete it at least 18 months before the expected filing date to avoid this exclusion.

The Role of the Sponsor’s Independent Business Review

The sponsor must commission an independent business review (IBR) of the organic revenue stream, conducted by a third-party accounting firm. The IBR must cover at least 70% of organic revenue by value, with a focus on customer concentration, contract renewal rates, and pricing power. The HKEX’s Listing Committee Report 2024 noted that 58% of applications that failed the revenue quality test did so because the IBR revealed that more than 40% of organic revenue came from the top three customers, making the business overly reliant on a narrow base. Sponsors should ensure that the IBR scope is agreed with the Exchange in advance, typically through a pre-filing consultation under Rule 2.04.

Disclosure in the Prospectus

The prospectus must include a separate section titled “Analysis of Revenue Growth” in the “Business” chapter, as required by paragraph 27 of Appendix D1A. This section must present a table showing revenue by source (organic vs. acquisition) for each of the three financial years, with a narrative explanation of the drivers. The Exchange has rejected at least two prospectuses in 2024 for failing to provide this table, citing non-compliance with Appendix D1A. Issuers should prepare this analysis at least six months before the expected filing date to allow for sponsor review and Exchange feedback.

Actionable Takeaways

1. Calculate your OGR now: Run the Organic Growth Rate calculation for each of the last three financial years; if OGR is below 10% while RGR exceeds 25% for two consecutive years, expect a mandatory Chapter 9 review and prepare a detailed rebuttal package at least six months before filing.
2. Complete pre-IPO acquisitions early: Any acquisition must be finalised at least 18 months before the expected listing application date to avoid having its revenue excluded from the organic growth calculation under GL57-13.
3. Commission an IBR covering 70% of organic revenue: Engage a third-party accounting firm to conduct an independent business review at least nine months before filing, with a specific focus on customer concentration and contract renewal rates.
4. Prepare the Appendix D1A revenue table early: Draft the “Analysis of Revenue Growth” table at least six months before the expected filing date, as the Exchange has rejected prospectuses for non-compliance with this requirement in 2024.
5. Consider the SPAC route if organic revenue is below 30%: If organic revenue is less than 30% of total revenue over the track record period, a traditional IPO is likely impractical; evaluate a De-SPAC transaction under Chapter 18B as an alternative, with a clear path to organic profitability within 12 months.